VectivBio Holding AG

VECTNASDAQHealthcare

$16.87

+$0.02(+0.12%)

Market Cap$1.1B

P/E Ratio—

52W High$16.98

52W Low$4.25

Avg Volume1.3M

Open$16.80

Beta0.10

Free Cash Flow Financials Revenue

VectivBio Holding AG (VECT) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

VECT · free cash flow · updated Jun 9, 2026

Core FCF metrics

VECT · FCF · TTM · margin & CAGR

Free cash flow was −$56.3M for FY2022 (fiscal year ending 2022-12-31), up 22.0% year-over-year The FCF margin was -206.0%.

FY2022 Free Cash Flow−$56.3M▲ +22.0% YoY

Trailing 12M (TTM)−$128.5Mtrailing 4 quarters sum

FCF Margin-206.0%−$56.3M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

VECT · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2022Latest−$56.3M(0M)−$56.3M▲ +22.0%-206.0%

FY2021−$72.1M(0M)−$72.2M▼ 88.5%—

FY2020−$38.2M(0M)−$38.3M▼ 156.2%—

FY2019−$14.9M(0M)−$15.0M——

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

VECT · P/FCF · FCF yield · FCF per share

VectivBio Holding AG (VECT) reported negative free cash flow of −$0.06B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2022 · 2022-12-31

Cash flow statement summary

VECT · cash flow statement · operating / investing / financing

For FY2022, VectivBio Holding AG generated −$56.3M in operating cash flow and spent 0M in capital expenditures, yielding −$56.3M in free cash flow.

Operating Activities

−$56.3M

Cash from core business operations

2022-12-31

Investing Activities

−$0.1M

CapEx, acquisitions & investments

2022-12-31

Financing Activities

+$175.1M

Buybacks, dividends & debt

2022-12-31

FCF FormulaOperating CF (−$56.3M) − |CapEx| (0M) = FCF (−$56.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

VECT vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

VectivBio Holding AGYOU

VECT

−$56.3M+22.0%-206.0%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

VectivBio Holding AG (VECT) reported free cash flow of −$56.3M for FY2022 (fiscal year ending 2022-12-31), up 22.0% year-over-year. The FCF margin was -206.0%.

VectivBio Holding AG has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 4 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

VECT free cash flow · 8 questions

VectivBio Holding AG free cash flow was −$56.3M for FY2022, up 22.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$128.5M.

VECT free cash flowVECT FCFVECT FCF 2022VECT free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · VectivBio Holding AG · VectivBio Holding AG SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026